Juravinski Hospital and Cancer Centre Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02751710
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Juravinski Cancer Centre at Hamilton Health Sciences Centre, Hamilton, ON Canada | Juravinski Hospital and Cancer Centre

Active Ingredients

Drugs in Phase 4 Trials (2)

cefazolin (ancef) (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Phase 2 Trials (2)

durvalumab (imfinzi) (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Other Trials (1)

fludeoxyglucose f-18 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Infections (Phase 4)

Surgical Wound Infection (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5